An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2013

Conditions
Infantile Spasms
Interventions
DRUG

Vigabatrin

Oral vigabatrin as a single 25 mg/kg dose on Days 1 and 5, 25 mg/kg twice a day (50 mg/kg daily dose, orally) on Days 2-4

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lundbeck LLC

INDUSTRY